Survival time of AIDS patients in Bamrasnaradura Institute.
A retrospective cohort study compared the survival time of AIDS patients, or HIV infected patients who had a CD4 count less than 200 cell/mm3, who had Thailands local triple anti-retroviral drugs regimen (GPO-VIR) with original triple anti-retroviral therapy without protease inhibitor in Bamrasnaradura Institute. The result proved that survival time in patients who had local anti-retroviral drugs was the same as patients who had original triple anti-retroviral therapy without protease inhibitor (log rank p-value = 0.9617). In conclusion, local anti-retroviral drugs can be used to prolong patients' survival time as much as original triple anti-retroviral therapy without protease inhibitor
Chaovavanich
Achara
A
Bamrasnaradura Infectious Institute, Ministry of Public Health, Nonthaburi, Thailand.
Chottanapund
Suthat
S
Ausavapipit
Jarurnsook
J
Adulyawat
Nipa
N
Ubonsai
Waritsara
W
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy* / Q000401:mortality*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012189:Retrospective Studies; D015996:Survival Rate; D013785:Thailand / Q000453:epidemiology; D013997:Time Factors
D044966:Anti-Retroviral Agents; D011480:Protease Inhibitors